Home › Companies › AMICUS THERAPEUTICS INC. › 2023-2024
Compiled from SEC Form N-PX filings and AMICUS THERAPEUTICS INC.’s Form 8-K, filed June 7, 2024 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of June 6, 2024: 6 items on AMICUS THERAPEUTICS INC.’s Form 8-K, filed June 7, 2024: 6 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore AMICUS THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are AMICUS THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 7, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Eiry W. Roberts | 248,107,021 | -- | -- | 6,738,791 | 11,256,697 | 97% | Not verified | — |
| Elect Director: Craig A. Wheeler | 248,172,753 | -- | -- | 6,673,059 | 11,256,697 | 97% | Not verified | — |
| Elect Director: Burke W. Whitman | 245,493,258 | -- | -- | 9,352,554 | 11,256,697 | 96% | Not verified | — |
| 2. Approval of the Amended and Restated 2007 Equity Incentive Plan | 245,475,071 | 9,101,663 | 269,078 | -- | 11,256,697 | 96% | Not verified | — |
| 3. Ratification of Ernst & Young LLC as the Company's Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2023 | 258,841,833 | 7,207,672 | 53,004 | -- | -- | 97% | Not verified | — |
| 4. Approval, on an advisory basis, of the Company's executive compensation | 246,376,429 | 6,826,611 | 1,642,772 | -- | 11,256,697 | 97% | Not verified | — |
Source: AMICUS THERAPEUTICS INC., Form 8-K, filed with the SEC on June 7, 2024 — read the filing on EDGAR.
Each item below shows how the 257 asset managers that disclosed a AMICUS THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Burke W. Whitman
AMICUS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Burke W. Whitman”): 245,493,258 for, 9,352,554 withheld, per its Form 8-K filed June 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 72 asset managers below reported 119,625,238 for, 4,520,447 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 41,211,247 | 0 | 0 | 0 | For |
| BlackRock | 12,142,745 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 9,913,817 | 0 | 0 | 0 | For |
| JPMorgan | 9,494,818 | 0 | 0 | 0 | For |
| Fidelity | 7,699,588 | 0 | 0 | 0 | For |
| State Street | 6,277,081 | 0 | 0 | 1,404 | For |
| Delaware/Macquarie | 5,330,861 | 0 | 0 | 0 | For |
| American Century | 4,724,247 | 0 | 0 | 0 | For |
| Invesco | 0 | 0 | 0 | 2,909,268 | Withhold |
| WILLIAM BLAIR FUNDS | 2,479,630 | 0 | 0 | 0 | For |
| Charles Schwab | 2,331,884 | 0 | 0 | 0 | For |
| MFS | 2,291,665 | 0 | 0 | 0 | For |
| Victory Capital | 1,368,836 | 0 | 0 | 0 | For |
| TIAA | 1,361,840 | 0 | 0 | 0 | For |
| Jackson National | 1,322,143 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,094,200 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 998,547 | Withhold |
| AIG/SunAmerica | 803,524 | 0 | 0 | 0 | For |
| Voya | 774,359 | 0 | 0 | 0 | For |
| Equitable | 446,111 | 0 | 0 | 316,459 | Mixed |
| New York Life | 617,896 | 0 | 0 | 0 | For |
| Lincoln Financial | 613,789 | 0 | 0 | 0 | For |
| Aberdeen | 604,402 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 576,264 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 540,984 | 0 | 0 | 0 | For |
Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Craig A. Wheeler
AMICUS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Craig A. Wheeler”): 248,172,753 for, 6,673,059 withheld, per its Form 8-K filed June 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 72 asset managers below reported 122,862,189 for, 1,283,496 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 41,211,247 | 0 | 0 | 0 | For |
| BlackRock | 12,142,745 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 9,913,817 | 0 | 0 | 0 | For |
| JPMorgan | 9,494,818 | 0 | 0 | 0 | For |
| Fidelity | 7,699,588 | 0 | 0 | 0 | For |
| State Street | 6,277,815 | 0 | 0 | 670 | For |
| Delaware/Macquarie | 5,330,861 | 0 | 0 | 0 | For |
| American Century | 4,724,247 | 0 | 0 | 0 | For |
| Invesco | 2,909,268 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 2,479,630 | 0 | 0 | 0 | For |
| Charles Schwab | 2,331,884 | 0 | 0 | 0 | For |
| MFS | 2,291,665 | 0 | 0 | 0 | For |
| Victory Capital | 1,368,836 | 0 | 0 | 0 | For |
| TIAA | 1,361,840 | 0 | 0 | 0 | For |
| Jackson National | 1,322,143 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,094,200 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 998,547 | Withhold |
| AIG/SunAmerica | 803,524 | 0 | 0 | 0 | For |
| Voya | 774,359 | 0 | 0 | 0 | For |
| Equitable | 762,570 | 0 | 0 | 0 | For |
| New York Life | 617,896 | 0 | 0 | 0 | For |
| Lincoln Financial | 613,789 | 0 | 0 | 0 | For |
| Aberdeen | 604,402 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 576,264 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 540,984 | 0 | 0 | 0 | For |
Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Eiry W. Roberts
AMICUS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Eiry W. Roberts”): 248,107,021 for, 6,738,791 withheld, per its Form 8-K filed June 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 72 asset managers below reported 122,862,189 for, 1,283,496 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 41,211,247 | 0 | 0 | 0 | For |
| BlackRock | 12,142,745 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 9,913,817 | 0 | 0 | 0 | For |
| JPMorgan | 9,494,818 | 0 | 0 | 0 | For |
| Fidelity | 7,699,588 | 0 | 0 | 0 | For |
| State Street | 6,277,815 | 0 | 0 | 670 | For |
| Delaware/Macquarie | 5,330,861 | 0 | 0 | 0 | For |
| American Century | 4,724,247 | 0 | 0 | 0 | For |
| Invesco | 2,909,268 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 2,479,630 | 0 | 0 | 0 | For |
| Charles Schwab | 2,331,884 | 0 | 0 | 0 | For |
| MFS | 2,291,665 | 0 | 0 | 0 | For |
| Victory Capital | 1,368,836 | 0 | 0 | 0 | For |
| TIAA | 1,361,840 | 0 | 0 | 0 | For |
| Jackson National | 1,322,143 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,094,200 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 998,547 | Withhold |
| AIG/SunAmerica | 803,524 | 0 | 0 | 0 | For |
| Voya | 774,359 | 0 | 0 | 0 | For |
| Equitable | 762,570 | 0 | 0 | 0 | For |
| New York Life | 617,896 | 0 | 0 | 0 | For |
| Lincoln Financial | 613,789 | 0 | 0 | 0 | For |
| Aberdeen | 604,402 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 576,264 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 540,984 | 0 | 0 | 0 | For |
Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.
Combines 5 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: APPROVAL OF THE AMENDED AND RESTATED 2007 EQUITY INCENTIVE PLAN TO ADD 7,000,000 SHARES TO THE EQUITY POOL.
AMICUS THERAPEUTICS INC.’s own tally for this item (“2. Approval of the Amended and Restated 2007 Equity Incentive Plan”): 245,475,071 for, 9,101,663 against, per its Form 8-K filed June 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 41,211,247 | 0 | 0 | 0 | For |
| BlackRock | 12,142,745 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 9,913,817 | 0 | 0 | 0 | For |
| JPMorgan | 9,494,818 | 0 | 0 | 0 | For |
| Fidelity | 7,699,588 | 0 | 0 | 0 | For |
| State Street | 6,277,449 | 1,036 | 0 | 0 | For |
| Delaware/Macquarie | 5,330,861 | 0 | 0 | 0 | For |
| American Century | 0 | 4,724,247 | 0 | 0 | Against |
| Invesco | 2,909,268 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 2,479,630 | 0 | 0 | 0 | For |
| Charles Schwab | 2,331,884 | 0 | 0 | 0 | For |
| MFS | 2,291,665 | 0 | 0 | 0 | For |
| Victory Capital | 1,368,836 | 0 | 0 | 0 | For |
| TIAA | 1,361,840 | 0 | 0 | 0 | For |
| Jackson National | 1,322,143 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,094,200 | 0 | 0 | 0 | For |
| T. Rowe Price | 998,547 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 803,524 | 0 | 0 | 0 | For |
| Voya | 774,359 | 0 | 0 | 0 | For |
| Equitable | 762,570 | 0 | 0 | 0 | For |
| New York Life | 617,896 | 0 | 0 | 0 | For |
| Lincoln Financial | 537,137 | 76,652 | 0 | 0 | Mixed |
| Aberdeen | 604,402 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 499,068 | 77,196 | 0 | 0 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 540,984 | 0 | 0 | 0 | For |
Fund voting reports, all 75 managers: 119,499,601 for, 4,912,760 against, 33,288 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Palo Alto Investors LP | 9,029,842 | 0 | 0 | 0 | For |
| Saturn V Capital Management LP | 500,947 | 0 | 0 | 0 | For |
| Lorne Steinberg Wealth Management Inc. | 0 | 4 | 0 | 0 | Against |
Institutional-manager reports, all 3 managers: 9,530,789 for, 4 against.
Combines 12 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: APPROVAL, ON AN ADVISORY BASIS, THE COMPANY'S EXECUTIVE COMPENSATION.
AMICUS THERAPEUTICS INC.’s own tally for this item (“4. Approval, on an advisory basis, of the Company's executive compensation”): 246,376,429 for, 6,826,611 against, per its Form 8-K filed June 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of AMICUS THERAPEUTICS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (4 managers, 16,174,029 for, 600 against).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 41,211,247 | 0 | 0 | 0 | For |
| BlackRock | 12,142,745 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 9,913,817 | 0 | 0 | 0 | For |
| JPMorgan | 9,494,818 | 0 | 0 | 0 | For |
| Fidelity | 7,699,588 | 0 | 0 | 0 | For |
| State Street | 6,278,485 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 5,330,861 | 0 | 0 | 0 | For |
| American Century | 4,724,247 | 0 | 0 | 0 | For |
| Invesco | 2,909,268 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 2,479,630 | 0 | 0 | 0 | For |
| Charles Schwab | 2,331,884 | 0 | 0 | 0 | For |
| MFS | 2,291,665 | 0 | 0 | 0 | For |
| Victory Capital | 1,368,836 | 0 | 0 | 0 | For |
| TIAA | 1,361,840 | 0 | 0 | 0 | For |
| Jackson National | 1,322,143 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,094,200 | 0 | 0 | 0 | For |
| T. Rowe Price | 998,547 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 803,524 | 0 | 0 | 0 | For |
| Voya | 774,359 | 0 | 0 | 0 | For |
| Equitable | 762,570 | 0 | 0 | 0 | For |
| New York Life | 617,896 | 0 | 0 | 0 | For |
| Lincoln Financial | 613,789 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 604,402 | 0 | 0 | Against |
| Bridge Builder Trust | 576,264 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 540,984 | 0 | 0 | 0 | For |
Fund voting reports, all 75 managers: 123,369,355 for, 1,043,006 against, 33,288 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 24,486,334 | 0 | 0 | 0 | For |
| Wellington | 17,470,228 | 0 | 0 | 0 | For |
| Janus Henderson | 13,166,124 | 0 | 0 | 0 | For |
| Redmile Group, LLC | 12,378,803 | 0 | 0 | 0 | For |
| State Street | 11,607,400 | 0 | 0 | 0 | For |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 9,742,127 | 0 | 0 | 0 | For |
| Palo Alto Investors LP | 9,029,842 | 0 | 0 | 0 | For |
| BlackRock | 8,742,750 | 0 | 0 | 0 | For |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 6,271,445 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 6,197,159 | 0 | 0 | 0 | For |
| Fiera Capital Corp | 4,704,442 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 4,600,894 | 0 | 0 | 0 | For |
| American Century | 4,456,511 | 0 | 0 | 0 | For |
| Invesco | 3,022,909 | 0 | 0 | 0 | For |
| Northern Trust | 2,750,226 | 196 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 2,557,543 | 0 | 0 | 0 | For |
| Victory Capital | 2,408,614 | 0 | 0 | 0 | For |
| Charles Schwab | 2,331,884 | 0 | 0 | 0 | For |
| Fidelity | 1,753,085 | 0 | 0 | 0 | For |
| NEW YORK STATE COMMON RETIREMENT FUND | 1,550,440 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 1,532,385 | 0 | 0 | Against |
| T. Rowe Price | 1,504,346 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 1,490,928 | 0 | 0 | 0 | For |
| Avoro Capital Advisors LLC | 1,447,123 | 0 | 0 | 0 | For |
| GREAT POINT PARTNERS LLC | 0 | 0 | 1,393,806 | 0 | Abstain |
Institutional-manager reports, all 201 managers: 177,576,926 for, 3,418,864 against, 1,395,769 abstained, 11,578 not voted. Showing the 25 largest; see all in the interactive database.
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.
AMICUS THERAPEUTICS INC.’s own tally for this item (“3. Ratification of Ernst & Young LLC as the Company's Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2023”): 258,841,833 for, 7,207,672 against, per its Form 8-K filed June 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 75 asset managers below reported 123,785,001 for, 627,360 against, 33,288 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 41,211,247 | 0 | 0 | 0 | For |
| BlackRock | 12,142,745 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 9,913,817 | 0 | 0 | 0 | For |
| JPMorgan | 9,494,818 | 0 | 0 | 0 | For |
| Fidelity | 7,699,588 | 0 | 0 | 0 | For |
| State Street | 6,277,449 | 1,036 | 0 | 0 | For |
| Delaware/Macquarie | 5,330,861 | 0 | 0 | 0 | For |
| American Century | 4,724,247 | 0 | 0 | 0 | For |
| Invesco | 2,909,268 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 2,479,630 | 0 | 0 | 0 | For |
| Charles Schwab | 2,331,884 | 0 | 0 | 0 | For |
| MFS | 2,291,665 | 0 | 0 | 0 | For |
| Victory Capital | 1,368,836 | 0 | 0 | 0 | For |
| TIAA | 1,361,840 | 0 | 0 | 0 | For |
| Jackson National | 1,322,143 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,094,200 | 0 | 0 | 0 | For |
| T. Rowe Price | 998,547 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 803,524 | 0 | 0 | 0 | For |
| Voya | 774,359 | 0 | 0 | 0 | For |
| Equitable | 762,570 | 0 | 0 | 0 | For |
| New York Life | 617,896 | 0 | 0 | 0 | For |
| Lincoln Financial | 613,789 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 604,402 | 0 | 0 | Against |
| Bridge Builder Trust | 576,264 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 540,984 | 0 | 0 | 0 | For |
Showing the 25 largest of 75 asset managers. See all 75 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported.
| # | Asset manager | Shares voted |
|---|---|---|
| 1 | Vanguard | 41,211,247 |
| 2 | BlackRock | 12,142,745 |
| 3 | JANUS INVESTMENT FUND | 9,913,817 |
| 4 | JPMorgan | 9,494,818 |
| 5 | Fidelity | 7,699,588 |
| 6 | State Street | 6,278,485 |
| 7 | Delaware/Macquarie | 5,330,861 |
| 8 | American Century | 4,724,247 |
| 9 | Invesco | 2,909,268 |
| 10 | WILLIAM BLAIR FUNDS | 2,479,630 |
| # | Asset manager | Shares voted |
|---|---|---|
| 1 | PERCEPTIVE ADVISORS LLC | 24,486,334 |
| 2 | Wellington | 17,470,228 |
| 3 | Janus Henderson | 13,166,124 |
| 4 | Redmile Group, LLC | 12,378,803 |
| 5 | State Street | 11,607,400 |
| 6 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 9,742,127 |
| 7 | Palo Alto Investors LP | 9,029,842 |
| 8 | BlackRock | 8,742,750 |
| 9 | MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 6,271,445 |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 6,197,159 |
Shown as share counts, not percentages: no shares-outstanding figure has been matched to AMICUS THERAPEUTICS INC. for the 2023-2024 season, so there is no denominator to divide by.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At AMICUS THERAPEUTICS INC.'s shareholder meeting held June 6, 2024, in the 2023-2024 proxy season, 257 asset managers reported how they voted on 6 ballot items in their SEC Form N-PX filings, covering 1,856 separate fund positions. On the most widely held item on that ballot — APPROVAL, ON AN ADVISORY BASIS, THE COMPANY'S EXECUTIVE COMPENSATION. — FOR was 97% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: AMICUS THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 7, 2024.
AMICUS THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.